SciFi Futures
← Concepts
Neurotechnology

Drug-delivered brain-to-brain network

Nanoparticles swallowed as a dose that self-assemble into a programmable interface in the brain, letting users share sensations, emotions and skills and run software on their own minds.

In shortDrug-delivered brain-to-brain network, from Nexus (Ramez Naam, 2012), is at technology readiness level 2 of 9 (technology concept formulated) at its weakest link. Held back by High-bandwidth brain-to-brain link and Cross-brain neural code alignment. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $115B–575B (a floor; some parts are priced only to early research).

The Nexus 5 dose installs a wireless, programmable nano-interface in the user's neurons, enabling shared sensoria, transmitted skills and back-door control of other users.
Nexus by Ramez Naam, 2012Set in 2040Not by then14 years left to climb 6 TRL steps (2.3 yrs/step)

Closest todayBrainNet's EEG-to-TMS binary link between three people; magnetoelectric nanoparticles that stimulate neurons wirelessly in mice.

Dependency stack

Research TRL 1–3Development TRL 4–6Deployment TRL 7–9
Sort by
    • Signals must be translated between two different neural codes
      • Idiosyncratic coding; functional alignment currently needs both people to view the same long stimulus set
      • No measurement of whether an aligned pattern evokes the same subjective content
      • Channel capacity; achieved brain-to-brain bit rates are of order bits per minute
      plausibleTRL 2
      • Alignment is composed of a decoder in one brain and an encoder in the other
        ✕3 blockers›
        • Models are subject-specific; decoders do not transfer across brains without recalibration
        • Non-invasive signals are slow and spatially coarse; invasive coverage is a few square centimetres
        • Encoding (write) models are far behind decoding; we cannot specify the activity for an arbitrary percept
        TRL 3
        • Fast, fine-grained signals needed for anything beyond coarse category decoding
          ✕2 blockers›
          • Tissue response degrades signal over years
          • Channel count and wireless bandwidth
          TRL 6
          • Channel count is limited by wireless data and power budget
            ✕3 blockers›
            • Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
            • Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
            • Battery or wireless-power lifetime versus the decades a permanent interface implies
            TRL 5
            • Implant power density sets what telemetry and on-board compute are affordable
              ✕2 blockers›
              • Cycle life of lithium-metal anodes
              • Thermal runaway safety
              TRL 6
        • Deep generative and language models supply the latent spaces that brain activity is mapped onto
          ✕2 blockers›
          • Reliability and calibration over long horizons
          • Continual learning after deployment
          TRL 7
          • Training and inference compute
            ✕2 blockers›
            • Grid power and interconnection queues
            • Advanced-node chip and HBM memory supply
            TRL 8
    • The receiving brain needs rich writing, not just a TMS pulse
      ✕4 blockers›
      • Simultaneous stimulation and recording on the same tissue; stimulation artifact swamps spikes
      • Coverage; immersive vision alone implies millions of controllable sites across V1
      • Suppressing the real senses so the artificial stream is not in conflict with them
      • Total implant power and heat once millions of channels are driven
      plausibleTRL 3
    • A shared neural channel must be authenticated to be usable at all
      ✕3 blockers›
      • Implant power and latency budgets limit cryptographic strength and attestation
      • Decoders leak content the user did not intend to transmit; filtering requires classifying intent
      • No verified safety kernel that bounds stimulation regardless of compromised higher software
      TRL 4
  • Transmitted skills and sensations must be translated between different brains
    plausibleTRL 2
  • An oral dose that becomes an interface is a self-assembling nanoscale device
    ✕3 blockers›
    • No scheme to individually power and address millions of untethered sub-cellular devices
    • Egress bandwidth; nanoparticles can stimulate but cannot yet report spikes off-board
    • Clearance, aggregation and long-term toxicity of persistent intraparenchymal devices
    plausibleTRL 3
    • Non-surgical delivery requires crossing from blood into brain parenchyma
      ✕3 blockers›
      • Receptor targeting is species-specific; capsids binding human TfR1 often fail in macaque
      • Pre-existing anti-AAV immunity excludes a large fraction of patients and blocks redosing
      • Dose needed for brain-wide coverage drives liver toxicity and manufacturing cost
      TRL 4
      • Designed capsid and shuttle proteins are the main route to receptor-specific transcytosis
        ✕1 blocker›
        • Designing catalysis and conformational dynamics
        TRL 6
    • Devices resident in tissue for decades must not provoke encapsulation
      ✕3 blockers›
      • Micromotion between rigid device and pulsating tissue drives chronic inflammation
      • Thin-film encapsulation (polyimide, parylene, SiC) eventually admits water and fails
      • Electrode charge-injection limits and corrosion under years of continuous stimulation
      TRL 4
  • The dose must cross from gut to bloodstream into neurons brain-wide
    TRL 4
  • The plot turns on remote back doors into users' motor and emotional control
    TRL 4

Who could unlock it

  • Across several requirements:
  • Rajesh Rao 2
  • Alexander Huth 2
High-bandwidth brain-to-brain linkTRL 2bottleneck
  • Rajesh RaoResearcher, University of Washington
    Co-led BrainNet, the three-person EEG/TMS brain-to-brain link that solved a Tetris-like task (Scientific Reports 2019)
  • Andrea StoccoResearcher, University of Washington
    Co-led the University of Washington human brain-to-brain interface experiments, including BrainNet (2019)
  • Miguel NicolelisResearcher, Duke University
    Demonstrated the first rat-to-rat brain-to-brain sensorimotor link with implanted electrodes (Scientific Reports 2013)
  • Alexander HuthResearcher, University of Texas at Austin
    Showed semantic decoders can be transferred to new people via functional alignment (Current Biology 2025), a building block for cross-brain translation
Cross-brain neural code alignmentTRL 2bottleneck
  • Alexander HuthResearcher, University of Texas at Austin
    Transferred semantic language decoders to new participants using functional alignment on stories or silent movies (Current Biology 2025)
  • James HaxbyResearcher, Dartmouth College
    Developed hyperalignment, the standard method for mapping fMRI representations between individuals
  • Uri HassonResearcher, Princeton University
    Showed speaker and listener brain activity couple during natural communication
  • Jean-Rémi KingResearcher, Meta FAIR
    Leads Meta's brain-decoding team, including functional alignment of visual semantics across subjects and Brain2Qwerty MEG decoding (2025-2026)
Injectable and self-implanting nanoscale neural interfacesTRL 3
  • Deblina SarkarResearcher, MIT Media Lab
    Circulatronics: immune-cell-electronics hybrids injected into the blood self-implanted in a target mouse brain region and were wirelessly powered (Nature Biotechnology 2025)
  • Jacob RobinsonResearcher, Rice University
    Magnetoelectric wireless power for distributed battery-free implant networks (Nature Biomedical Engineering 2025)
  • Jia LiuResearcher, Harvard SEAS
    Co-inventor of syringe-injectable mesh electronics; 2025 Nature Electronics paper on wireless ultrathin brain interfaces
  • SynchronStartup
    Endovascular Stentrode in 10 patients by 2025; developing a transcatheter high-channel whole-brain interface
Systemic delivery of agents across the blood-brain barrierTRL 4
  • Benjamin DevermanResearcher, Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
    Engineered BI-hTFR1, an AAV9 capsid reprogrammed to bind human transferrin receptor, giving 40-50x more CNS expression than AAV9 in human TFRC knock-in mice (Science, 2024)
  • Denali TherapeuticsCompany
    Its TransportVehicle platform produced AVLAYAH (tividenofusp alfa), approved by the FDA in March 2026 as the first biologic specifically designed to cross the blood-brain barrier
  • Voyager TherapeuticsCompany
    Used its TRACER platform to find cross-species BBB-penetrant capsids and identified ALPL as the receptor they use; VCAP-102 gave 20-400x more brain gene transfer than AAV9 in primates (2025)
  • Sangamo TherapeuticsCompany
    Reported its STAC-BBB capsid achieving widespread brain transduction after intravenous dosing in non-human primates at clinically relevant doses (2024)
Trustworthy neural implant securityTRL 4
  • Luciano FloridiResearcher, Yale Digital Ethics Center
    Co-authored the 2025 Neuroethics analysis of BCI cyber risk recommending mandated non-surgical update paths, strong authentication and transit encryption
  • Rafael YusteResearcher, Columbia University
    Founder of the neurorights movement; drove the first hard-law neural-data protections, starting with Colorado HB 24-1058 in force August 2024
  • Neurorights FoundationProgram
    Co-drafted the neural-data amendments enacted in Colorado, California, Montana and Connecticut (2024-2025) and briefed the FTC in April 2025
  • MIND Act of 2025 (S.2925)Program
    Cantwell/Schumer/Markey bill directing the FTC to assess neural-data security gaps and bar federal agencies from non-compliant neurotechnology

Beyond engineering

  • Dual use, since the same interface can coerce as easily as connect
  • Drug-law framing of a device that is swallowed rather than implanted